Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population
- PMID: 11589684
- DOI: 10.1046/j.1365-2265.2001.01328.x
Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population
Abstract
Objective: The molecular basis of sporadic medullary thyroid carcinoma (MTC) remains elusive. While germline gain-of-function mutations in the RET proto-oncogene cause hereditary MTC, somatic activating RET mutations and loss of heterozygosity of markers in various chromosomal regions representing deletions of tumour suppressor genes, have been described in a variable number of sporadic MTC. A previous report suggested that the presence of a germline variant at RET codon 836 (S836S) was associated with the development of sporadic MTC and, furthermore, that the presence of S836S was highly correlated with somatic RET M918T mutation in the MTC. Thus, we sought to determine if the S836S variant would be associated with sporadic MTC from a completely different population base, that of Andalucia.
Design: This is a case-control study to determine whether the presence of RET germline S836S is correlated with sporadic MTC in Andalucia.
Patients: Thirty-two patients with sporadic MTC from the Andalucia region of Spain, serviced by our University Hospital, were ascertained throughout the period 1995-99. Sporadic MTC was defined as a lack of personal or family history suggestive of multiple endocrine neoplasia type 2 (MEN 2) and lack of germline RET mutations which define any MEN 2 subtype. A region and race matched cohort of 250 controls was also obtained.
Measurements: The frequency of the S836S allele was determined in cases and controls and compared using the standard chi-squared statistic and Fisher's exact test.
Results: The polymorphic allele frequency at codon 836 in the control population (18/500 chromosomes, 3.6%) differed significantly from the MTC case cohort, 9.3% of case chromosomes (six of 64 alleles, Fisher's exact test, two-tailed, P = 0.043).
Conclusions: Germline RET S836S variant is associated with a two- to three-fold risk of sporadic MTC in the Spanish population, in accordance with a previous study based on German cases. Our observations suggest that this phenomenon might be universal and not limited to Germany.
Similar articles
-
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.Oncogene. 1999 Feb 11;18(6):1369-73. doi: 10.1038/sj.onc.1202418. Oncogene. 1999. PMID: 10022819
-
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x. Clin Endocrinol (Oxf). 1995. PMID: 7641404
-
The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.Endocr Relat Cancer. 2010 Oct 5;17(4):953-63. doi: 10.1677/ERC-09-0312. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20801952
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.
-
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8. Mutat Res. 2013. PMID: 23059849 Review.
Cited by
-
Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma.Int J Mol Sci. 2021 Oct 30;22(21):11794. doi: 10.3390/ijms222111794. Int J Mol Sci. 2021. PMID: 34769224 Free PMC article. Clinical Trial.
-
Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms.Int J Mol Sci. 2012;13(1):221-39. doi: 10.3390/ijms13010221. Epub 2011 Dec 27. Int J Mol Sci. 2012. PMID: 22312249 Free PMC article. Review.
-
Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.J Endocrinol Invest. 2006 Nov;29(10):858-62. doi: 10.1007/BF03349187. J Endocrinol Invest. 2006. PMID: 17185892
-
Current status of the prognostic molecular markers in medullary thyroid carcinoma.Endocr Connect. 2020 Dec;9(12):R251-R263. doi: 10.1530/EC-20-0374. Endocr Connect. 2020. PMID: 33112827 Free PMC article. Review.
-
Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.Genes (Basel). 2019 Nov 8;10(11):913. doi: 10.3390/genes10110913. Genes (Basel). 2019. PMID: 31717449 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases